Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2015 3
2016 11
2017 5
2018 4
2019 4
2020 7
2021 3
2022 7
2023 7
2024 8
2025 14
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023.
Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators. Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators. J Am Coll Cardiol. 2025 Dec 2;86(22):2167-2243. doi: 10.1016/j.jacc.2025.08.015. Epub 2025 Sep 24. J Am Coll Cardiol. 2025. PMID: 40990886 Free article.
BACKGROUND: Cardiovascular diseases (CVDs) are the leading cause of mortality and are among the foremost causes of disability globally. ...Countries will need to adopt effective health system and public health strategies if they are to progress in achieving global g …
BACKGROUND: Cardiovascular diseases (CVDs) are the leading cause of mortality and are among the foremost causes of disability globall …
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias.
Mach F, Koskinas KC, Roeters van Lennep JE, Tokgözoğlu L, Badimon L, Baigent C, Benn M, Binder CJ, Catapano AL, De Backer GG, Delgado V, Fabin N, Ference BA, Graham IM, Landmesser U, Laufs U, Mihaylova B, Nordestgaard BG, Richter DJ, Sabatine MS; ESC/EAS Scientific Document Group. Mach F, et al. Eur Heart J. 2025 Nov 7;46(42):4359-4378. doi: 10.1093/eurheartj/ehaf190. Eur Heart J. 2025. PMID: 40878289 Free article. No abstract available.
Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers.
Antoniades C, Tousoulis D, Vavlukis M, Fleming I, Duncker DJ, Eringa E, Manfrini O, Antonopoulos AS, Oikonomou E, Padró T, Trifunovic-Zamaklar D, De Luca G, Guzik T, Cenko E, Djordjevic-Dikic A, Crea F. Antoniades C, et al. Among authors: cenko e. Eur Heart J. 2023 Oct 12;44(38):3827-3844. doi: 10.1093/eurheartj/ehad484. Eur Heart J. 2023. PMID: 37599464 Free PMC article. Review.
Obesity is a modifiable cardiovascular risk factor, but adipose tissue (AT) depots in humans are anatomically, histologically, and functionally heterogeneous. ...Special focus is given to the interactions between PVAT and the vascular wall that render PVAT a potential ther …
Obesity is a modifiable cardiovascular risk factor, but adipose tissue (AT) depots in humans are anatomically, histologically, and fu …
Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Chronic Kidney Disease Collaborators. GBD 2023 Chronic Kidney Disease Collaborators. Lancet. 2025 Nov 22;406(10518):2461-2482. doi: 10.1016/S0140-6736(25)01853-7. Epub 2025 Nov 7. Lancet. 2025. PMID: 41213283 Free article.
A comparative risk assessment approach estimated the proportion of cardiovascular deaths attributable to impaired kidney function and estimated risk factors for CKD. ...Impaired kidney function as a risk factor accounted for 11.5% (8.4-14.5) of cardiovascular deaths …
A comparative risk assessment approach estimated the proportion of cardiovascular deaths attributable to impaired kidney function and …
Pathophysiology, prevention, and management of coronary microvascular obstruction.
Cenko E, Badimon L, Vadalà G, Merkus D, Antoniades C, Collet C, De Maria GL, Djordjevic-Dikic A, Drenjancevic I, Escaned J, Ferreiro JL, Fleming I, Guzik T, Manfrini O, Milicic D, Padro T, Porto I, Riou LM, Ryan N, Tousoulis D, van Beusekom HMM, Vavlukis M, Vilahur G, Zdravkovic M, Duncker DJ, Galassi AR, Bugiardini R. Cenko E, et al. Eur Heart J. 2026 May 26:ehag334. doi: 10.1093/eurheartj/ehag334. Online ahead of print. Eur Heart J. 2026. PMID: 42185090 Free article.
Sex and gender differences in coronary pathophysiology and ischaemic heart disease.
Manfrini O, Tousoulis D, Antoniades C, Badimon L, Bugiardini R, Chieffo A, Crea F, De Luca G, Djordjevic-Dikic A, Drenjancevic I, Duncker DJ, Fleming I, Gallinoro E, Kunadian V, Galassi AR, Guzik TJ, Masip J, Merkus D, Milicic D, Pöss J, Riou L, Sambola A, Trifunovic-Zamaklar D, Tycinska A, Vavlukis M, Zdravkovic M, Cenko E, Padro T. Manfrini O, et al. Among authors: cenko e. Eur Heart J. 2026 Jun 9;47(22):2727-2749. doi: 10.1093/eurheartj/ehaf1059. Eur Heart J. 2026. PMID: 41571335 Free article. Review.
82 results